

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | chaperone-mediated protein transport (GO:0072321) | 5.09715037 |
| 2 | formation of translation preinitiation complex (GO:0001731) | 4.68165988 |
| 3 | respiratory electron transport chain (GO:0022904) | 4.61023433 |
| 4 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.59973660 |
| 5 | electron transport chain (GO:0022900) | 4.48768855 |
| 6 | ribosomal small subunit assembly (GO:0000028) | 4.41680457 |
| 7 | regulation of mitochondrial translation (GO:0070129) | 4.40926821 |
| 8 | purine nucleobase biosynthetic process (GO:0009113) | 4.39634009 |
| 9 | nucleobase biosynthetic process (GO:0046112) | 4.39413994 |
| 10 | ribosomal small subunit biogenesis (GO:0042274) | 4.37482372 |
| 11 | ribosome assembly (GO:0042255) | 4.34731852 |
| 12 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.15895383 |
| 13 | folic acid-containing compound biosynthetic process (GO:0009396) | 4.15879243 |
| 14 | cotranslational protein targeting to membrane (GO:0006613) | 4.11049888 |
| 15 | protein targeting to ER (GO:0045047) | 4.05929594 |
| 16 | * negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.98844784 |
| 17 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.89070303 |
| 18 | * positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.88866566 |
| 19 | * anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.87210484 |
| 20 | protein localization to endoplasmic reticulum (GO:0070972) | 3.86778040 |
| 21 | establishment of viral latency (GO:0019043) | 3.84049142 |
| 22 | * regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.80715006 |
| 23 | protein complex biogenesis (GO:0070271) | 3.80322833 |
| 24 | protein targeting to mitochondrion (GO:0006626) | 3.76111201 |
| 25 | mitotic metaphase plate congression (GO:0007080) | 3.70016978 |
| 26 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.69399409 |
| 27 | maturation of SSU-rRNA (GO:0030490) | 3.69119887 |
| 28 | DNA unwinding involved in DNA replication (GO:0006268) | 3.67716838 |
| 29 | proteasome assembly (GO:0043248) | 3.65909200 |
| 30 | protein neddylation (GO:0045116) | 3.65459979 |
| 31 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.65434772 |
| 32 | NADH dehydrogenase complex assembly (GO:0010257) | 3.65434772 |
| 33 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.65434772 |
| 34 | IMP biosynthetic process (GO:0006188) | 3.63783609 |
| 35 | folic acid metabolic process (GO:0046655) | 3.61711598 |
| 36 | * negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.61087922 |
| 37 | * negative regulation of ligase activity (GO:0051352) | 3.61087922 |
| 38 | cullin deneddylation (GO:0010388) | 3.59680747 |
| 39 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.58457592 |
| 40 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.58457592 |
| 41 | ribosome biogenesis (GO:0042254) | 3.56882507 |
| 42 | glycine metabolic process (GO:0006544) | 3.56391648 |
| 43 | * positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.56197534 |
| 44 | DNA replication initiation (GO:0006270) | 3.55656705 |
| 45 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.54561293 |
| 46 | establishment of protein localization to mitochondrion (GO:0072655) | 3.50879918 |
| 47 | protein localization to mitochondrion (GO:0070585) | 3.50498749 |
| 48 | * regulation of cellular amino acid metabolic process (GO:0006521) | 3.48748940 |
| 49 | viral life cycle (GO:0019058) | 3.48393934 |
| 50 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.47527643 |
| 51 | chaperone-mediated protein complex assembly (GO:0051131) | 3.47315412 |
| 52 | regulation of translational termination (GO:0006449) | 3.44380752 |
| 53 | cellular component biogenesis (GO:0044085) | 3.43549779 |
| 54 | cellular protein complex disassembly (GO:0043624) | 3.41939145 |
| 55 | IMP metabolic process (GO:0046040) | 3.40177350 |
| 56 | mitotic nuclear envelope disassembly (GO:0007077) | 3.39624860 |
| 57 | DNA damage response, detection of DNA damage (GO:0042769) | 3.39591507 |
| 58 | protein deneddylation (GO:0000338) | 3.35269412 |
| 59 | * positive regulation of ligase activity (GO:0051351) | 3.35078539 |
| 60 | spliceosomal snRNP assembly (GO:0000387) | 3.32590852 |
| 61 | serine family amino acid biosynthetic process (GO:0009070) | 3.31529140 |
| 62 | * DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.31118671 |
| 63 | * regulation of cellular amine metabolic process (GO:0033238) | 3.30270851 |
| 64 | DNA strand elongation (GO:0022616) | 3.29997404 |
| 65 | inner mitochondrial membrane organization (GO:0007007) | 3.29280858 |
| 66 | * signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.27232634 |
| 67 | * signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.27232634 |
| 68 | protein localization to kinetochore (GO:0034501) | 3.26157948 |
| 69 | * signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.25862538 |
| 70 | * intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.25862538 |
| 71 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.25238996 |
| 72 | * signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.22833648 |
| 73 | * signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.22833648 |
| 74 | * signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.22833648 |
| 75 | * DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 3.22170567 |
| 76 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.21774105 |
| 77 | * signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.21773430 |
| 78 | * negative regulation of protein ubiquitination (GO:0031397) | 3.20615452 |
| 79 | L-serine metabolic process (GO:0006563) | 3.20300511 |
| 80 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.19586230 |
| 81 | membrane disassembly (GO:0030397) | 3.19413147 |
| 82 | nuclear envelope disassembly (GO:0051081) | 3.19413147 |
| 83 | * regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.17788529 |
| 84 | ribosomal large subunit biogenesis (GO:0042273) | 3.17350762 |
| 85 | pseudouridine synthesis (GO:0001522) | 3.14249098 |
| 86 | DNA replication checkpoint (GO:0000076) | 3.14210136 |
| 87 | protein maturation by protein folding (GO:0022417) | 3.13306275 |
| 88 | translational initiation (GO:0006413) | 3.12585146 |
| 89 | ATP biosynthetic process (GO:0006754) | 3.08772221 |
| 90 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.07168406 |
| 91 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.04754866 |
| 92 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.03477309 |
| 93 | rRNA metabolic process (GO:0016072) | 3.02609699 |
| 94 | * negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 3.02244674 |
| 95 | * regulation of ligase activity (GO:0051340) | 3.01716667 |
| 96 | oxidative phosphorylation (GO:0006119) | 3.00703833 |
| 97 | protein complex disassembly (GO:0043241) | 2.99280273 |
| 98 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.98651636 |
| 99 | * cell cycle G1/S phase transition (GO:0044843) | 2.97693574 |
| 100 | * G1/S transition of mitotic cell cycle (GO:0000082) | 2.97693574 |
| 101 | * antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.96309209 |
| 102 | establishment of integrated proviral latency (GO:0075713) | 2.95842566 |
| 103 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.94899380 |
| 104 | translational elongation (GO:0006414) | 2.93657825 |
| 105 | metaphase plate congression (GO:0051310) | 2.93028531 |
| 106 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.91551047 |
| 107 | translational termination (GO:0006415) | 2.89807755 |
| 108 | rRNA modification (GO:0000154) | 2.87617862 |
| 109 | * antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.87190247 |
| 110 | L-methionine salvage (GO:0071267) | 2.86971115 |
| 111 | L-methionine biosynthetic process (GO:0071265) | 2.86971115 |
| 112 | amino acid salvage (GO:0043102) | 2.86971115 |
| 113 | regulation of spindle organization (GO:0090224) | 2.86604312 |
| 114 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.86281547 |
| 115 | spliceosomal complex assembly (GO:0000245) | 2.85845138 |
| 116 | viral transcription (GO:0019083) | 2.85724108 |
| 117 | nuclear pore organization (GO:0006999) | 2.85275407 |
| 118 | tRNA aminoacylation for protein translation (GO:0006418) | 2.84301916 |
| 119 | tetrahydrofolate metabolic process (GO:0046653) | 2.84113415 |
| 120 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.83678135 |
| 121 | 7-methylguanosine mRNA capping (GO:0006370) | 2.83136618 |
| 122 | rRNA processing (GO:0006364) | 2.81462549 |
| 123 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.81169454 |
| 124 | ATP synthesis coupled proton transport (GO:0015986) | 2.81169454 |
| 125 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.80235336 |
| 126 | CENP-A containing nucleosome assembly (GO:0034080) | 2.79575746 |
| 127 | chromatin remodeling at centromere (GO:0031055) | 2.78732920 |
| 128 | * positive regulation of cell cycle arrest (GO:0071158) | 2.78614721 |
| 129 | serine family amino acid metabolic process (GO:0009069) | 2.78264849 |
| 130 | termination of RNA polymerase III transcription (GO:0006386) | 2.76698847 |
| 131 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.76698847 |
| 132 | tRNA aminoacylation (GO:0043039) | 2.75379017 |
| 133 | amino acid activation (GO:0043038) | 2.75379017 |
| 134 | translation (GO:0006412) | 2.75333772 |
| 135 | mitotic spindle assembly checkpoint (GO:0007094) | 2.73312486 |
| 136 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.73223317 |
| 137 | negative regulation of sister chromatid segregation (GO:0033046) | 2.73223317 |
| 138 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.73223317 |
| 139 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.73223317 |
| 140 | negative regulation of chromosome segregation (GO:0051985) | 2.72970483 |
| 141 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.72376524 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.74554860 |
| 2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.26341057 |
| 3 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.04545826 |
| 4 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.31318938 |
| 5 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.15518203 |
| 6 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.10713147 |
| 7 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.05929193 |
| 8 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.01819636 |
| 9 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.99089499 |
| 10 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.95995364 |
| 11 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.93549474 |
| 12 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.86533323 |
| 13 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.82130738 |
| 14 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.72598456 |
| 15 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.50758952 |
| 16 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.48275077 |
| 17 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.39478741 |
| 18 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.37157900 |
| 19 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.35812531 |
| 20 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.23246951 |
| 21 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.22349498 |
| 22 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.19959249 |
| 23 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.12264499 |
| 24 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.01887081 |
| 25 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.01206007 |
| 26 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.93333281 |
| 27 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.91326214 |
| 28 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.91324914 |
| 29 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.89931874 |
| 30 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.89743297 |
| 31 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.88802920 |
| 32 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.88079602 |
| 33 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.85703868 |
| 34 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.82107903 |
| 35 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.76622487 |
| 36 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.75841185 |
| 37 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.70601347 |
| 38 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.70302373 |
| 39 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.69624287 |
| 40 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.68656842 |
| 41 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.68467932 |
| 42 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.63318777 |
| 43 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.62784344 |
| 44 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.59620778 |
| 45 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.55740800 |
| 46 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.51558492 |
| 47 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.48836465 |
| 48 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.47781795 |
| 49 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.47067264 |
| 50 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.46116333 |
| 51 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.44449266 |
| 52 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.43694962 |
| 53 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.43145946 |
| 54 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.40287256 |
| 55 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.38865491 |
| 56 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.38811734 |
| 57 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.36122933 |
| 58 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.35827455 |
| 59 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.35220820 |
| 60 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.34390707 |
| 61 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.30873376 |
| 62 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.28701572 |
| 63 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.28701085 |
| 64 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.25888221 |
| 65 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.25814409 |
| 66 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.25749338 |
| 67 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.24707167 |
| 68 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.23019435 |
| 69 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.22378156 |
| 70 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.22141067 |
| 71 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.19926219 |
| 72 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.17496890 |
| 73 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.17321739 |
| 74 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.15720315 |
| 75 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.14623797 |
| 76 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.12651349 |
| 77 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.11911357 |
| 78 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.11417408 |
| 79 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.10802332 |
| 80 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.09779928 |
| 81 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.09735942 |
| 82 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.09555785 |
| 83 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09521887 |
| 84 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.08000269 |
| 85 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.07499409 |
| 86 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.05242044 |
| 87 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.04436037 |
| 88 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.04393113 |
| 89 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04259366 |
| 90 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.03491581 |
| 91 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.03177559 |
| 92 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.01612626 |
| 93 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.01160904 |
| 94 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.00697242 |
| 95 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00449499 |
| 96 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.99757493 |
| 97 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.99513120 |
| 98 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99052932 |
| 99 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.98754960 |
| 100 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.98213057 |
| 101 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.97305880 |
| 102 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.95926574 |
| 103 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.95476965 |
| 104 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.93221975 |
| 105 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.91689980 |
| 106 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.91630961 |
| 107 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.91457172 |
| 108 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.90772227 |
| 109 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.88438141 |
| 110 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.86819194 |
| 111 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.86502198 |
| 112 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.85130639 |
| 113 | * TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.83376868 |
| 114 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.81846359 |
| 115 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.81714237 |
| 116 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.81486963 |
| 117 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.78503754 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003806_abnormal_nucleotide_metabolis | 5.21736713 |
| 2 | MP0003693_abnormal_embryo_hatching | 4.81183369 |
| 3 | MP0004957_abnormal_blastocyst_morpholog | 4.14336918 |
| 4 | MP0003111_abnormal_nucleus_morphology | 3.32049497 |
| 5 | MP0003077_abnormal_cell_cycle | 3.19513009 |
| 6 | MP0010094_abnormal_chromosome_stability | 3.13676913 |
| 7 | MP0009379_abnormal_foot_pigmentation | 2.94411308 |
| 8 | MP0001730_embryonic_growth_arrest | 2.69568492 |
| 9 | MP0008932_abnormal_embryonic_tissue | 2.64745590 |
| 10 | MP0002139_abnormal_hepatobiliary_system | 2.46525453 |
| 11 | MP0003705_abnormal_hypodermis_morpholog | 2.43795614 |
| 12 | MP0001529_abnormal_vocalization | 2.33847709 |
| 13 | MP0003123_paternal_imprinting | 2.29408930 |
| 14 | MP0005360_urolithiasis | 2.29225990 |
| 15 | MP0003718_maternal_effect | 2.25717800 |
| 16 | MP0003186_abnormal_redox_activity | 2.17420859 |
| 17 | MP0002938_white_spotting | 2.14056896 |
| 18 | MP0000372_irregular_coat_pigmentation | 2.12725758 |
| 19 | MP0008789_abnormal_olfactory_epithelium | 2.12001023 |
| 20 | MP0006292_abnormal_olfactory_placode | 2.07189853 |
| 21 | MP0009840_abnormal_foam_cell | 2.02151867 |
| 22 | MP0010352_gastrointestinal_tract_polyps | 1.99159514 |
| 23 | MP0006036_abnormal_mitochondrial_physio | 1.92690149 |
| 24 | MP0008058_abnormal_DNA_repair | 1.90022784 |
| 25 | MP0000350_abnormal_cell_proliferation | 1.86963943 |
| 26 | MP0008007_abnormal_cellular_replicative | 1.85345147 |
| 27 | MP0003221_abnormal_cardiomyocyte_apopto | 1.82668037 |
| 28 | MP0005085_abnormal_gallbladder_physiolo | 1.78028057 |
| 29 | MP0003136_yellow_coat_color | 1.72097063 |
| 30 | MP0008057_abnormal_DNA_replication | 1.70085356 |
| 31 | MP0000750_abnormal_muscle_regeneration | 1.69885963 |
| 32 | MP0004084_abnormal_cardiac_muscle | 1.68988125 |
| 33 | MP0001672_abnormal_embryogenesis/_devel | 1.68548457 |
| 34 | MP0005380_embryogenesis_phenotype | 1.68548457 |
| 35 | MP0001697_abnormal_embryo_size | 1.67819988 |
| 36 | MP0002269_muscular_atrophy | 1.65978318 |
| 37 | MP0002080_prenatal_lethality | 1.59696915 |
| 38 | MP0003646_muscle_fatigue | 1.59656492 |
| 39 | MP0003941_abnormal_skin_development | 1.59416083 |
| 40 | MP0005499_abnormal_olfactory_system | 1.57978531 |
| 41 | MP0005394_taste/olfaction_phenotype | 1.57978531 |
| 42 | MP0006035_abnormal_mitochondrial_morpho | 1.57580119 |
| 43 | MP0003984_embryonic_growth_retardation | 1.54458439 |
| 44 | MP0003567_abnormal_fetal_cardiomyocyte | 1.52237219 |
| 45 | MP0002088_abnormal_embryonic_growth/wei | 1.51788452 |
| 46 | MP0009053_abnormal_anal_canal | 1.47995117 |
| 47 | MP0000358_abnormal_cell_content/ | 1.43546373 |
| 48 | MP0004197_abnormal_fetal_growth/weight/ | 1.40930562 |
| 49 | MP0000747_muscle_weakness | 1.38857770 |
| 50 | MP0010030_abnormal_orbit_morphology | 1.38225185 |
| 51 | MP0002102_abnormal_ear_morphology | 1.37103972 |
| 52 | MP0002085_abnormal_embryonic_tissue | 1.36668878 |
| 53 | MP0010307_abnormal_tumor_latency | 1.33729498 |
| 54 | MP0000749_muscle_degeneration | 1.31948400 |
| 55 | MP0002084_abnormal_developmental_patter | 1.30104087 |
| 56 | MP0005332_abnormal_amino_acid | 1.25169018 |
| 57 | MP0005365_abnormal_bile_salt | 1.23413417 |
| 58 | MP0005266_abnormal_metabolism | 1.22537245 |
| 59 | MP0002086_abnormal_extraembryonic_tissu | 1.22149647 |
| 60 | MP0009672_abnormal_birth_weight | 1.22111764 |
| 61 | MP0008995_early_reproductive_senescence | 1.21466174 |
| 62 | MP0000647_abnormal_sebaceous_gland | 1.21010077 |
| 63 | MP0008877_abnormal_DNA_methylation | 1.17285906 |
| 64 | MP0000537_abnormal_urethra_morphology | 1.17103386 |
| 65 | MP0003786_premature_aging | 1.15996465 |
| 66 | MP0003011_delayed_dark_adaptation | 1.11724300 |
| 67 | MP0005330_cardiomyopathy | 1.08179903 |
| 68 | MP0006072_abnormal_retinal_apoptosis | 1.08154568 |
| 69 | MP0003315_abnormal_perineum_morphology | 1.07740623 |
| 70 | MP0001905_abnormal_dopamine_level | 1.06594251 |
| 71 | MP0002653_abnormal_ependyma_morphology | 1.05581381 |
| 72 | MP0005083_abnormal_biliary_tract | 1.04910914 |
| 73 | MP0004133_heterotaxia | 1.04525544 |
| 74 | MP0005408_hypopigmentation | 1.03636316 |
| 75 | MP0002234_abnormal_pharynx_morphology | 1.03066703 |
| 76 | MP0005319_abnormal_enzyme/_coenzyme | 1.00677735 |
| 77 | MP0004087_abnormal_muscle_fiber | 0.99632453 |
| 78 | MP0000049_abnormal_middle_ear | 0.99198301 |
| 79 | MP0003937_abnormal_limbs/digits/tail_de | 0.98860173 |
| 80 | MP0004036_abnormal_muscle_relaxation | 0.98741458 |
| 81 | MP0000313_abnormal_cell_death | 0.98700535 |
| 82 | MP0002095_abnormal_skin_pigmentation | 0.96790617 |
| 83 | MP0004147_increased_porphyrin_level | 0.96755886 |
| 84 | MP0005084_abnormal_gallbladder_morpholo | 0.96347368 |
| 85 | MP0002837_dystrophic_cardiac_calcinosis | 0.95352387 |
| 86 | MP0008875_abnormal_xenobiotic_pharmacok | 0.94721061 |
| 87 | MP0002160_abnormal_reproductive_system | 0.94248863 |
| 88 | MP0002736_abnormal_nociception_after | 0.93463492 |
| 89 | MP0003119_abnormal_digestive_system | 0.91579618 |
| 90 | MP0003890_abnormal_embryonic-extraembry | 0.91019019 |
| 91 | MP0004233_abnormal_muscle_weight | 0.90703404 |
| 92 | MP0002163_abnormal_gland_morphology | 0.89846833 |
| 93 | MP0005171_absent_coat_pigmentation | 0.89767453 |
| 94 | MP0002090_abnormal_vision | 0.88146429 |
| 95 | MP0003950_abnormal_plasma_membrane | 0.87534707 |
| 96 | MP0008260_abnormal_autophagy | 0.87082449 |
| 97 | MP0002233_abnormal_nose_morphology | 0.86457325 |
| 98 | MP0005395_other_phenotype | 0.84476363 |
| 99 | MP0005187_abnormal_penis_morphology | 0.83791498 |
| 100 | MP0002019_abnormal_tumor_incidence | 0.83702685 |
| 101 | MP0001849_ear_inflammation | 0.82683135 |
| 102 | MP0002111_abnormal_tail_morphology | 0.82480125 |
| 103 | MP0003656_abnormal_erythrocyte_physiolo | 0.82133992 |
| 104 | MP0005023_abnormal_wound_healing | 0.81788972 |
| 105 | MP0000598_abnormal_liver_morphology | 0.81168534 |
| 106 | MP0000759_abnormal_skeletal_muscle | 0.80161855 |
| 107 | MP0001929_abnormal_gametogenesis | 0.79970019 |
| 108 | MP0002751_abnormal_autonomic_nervous | 0.79732360 |
| 109 | MP0005389_reproductive_system_phenotype | 0.78401729 |
| 110 | MP0001727_abnormal_embryo_implantation | 0.78324273 |
| 111 | MP0001764_abnormal_homeostasis | 0.77696460 |
| 112 | MP0002106_abnormal_muscle_physiology | 0.77626392 |
| 113 | MP0001293_anophthalmia | 0.77190362 |
| 114 | MP0002697_abnormal_eye_size | 0.77009145 |
| 115 | MP0005501_abnormal_skin_physiology | 0.76910828 |
| 116 | MP0003566_abnormal_cell_adhesion | 0.76155189 |
| 117 | MP0010329_abnormal_lipoprotein_level | 0.75955178 |
| 118 | MP0000733_abnormal_muscle_development | 0.75262361 |
| 119 | MP0002210_abnormal_sex_determination | 0.74737315 |
| 120 | MP0009697_abnormal_copulation | 0.74361752 |
| 121 | MP0000762_abnormal_tongue_morphology | 0.74221287 |
| 122 | MP0001286_abnormal_eye_development | 0.73777036 |
| 123 | MP0002332_abnormal_exercise_endurance | 0.73529220 |
| 124 | MP0003195_calcinosis | 0.73430615 |
| 125 | MP0000609_abnormal_liver_physiology | 0.72778711 |
| 126 | MP0000751_myopathy | 0.72115748 |
| 127 | MP0000653_abnormal_sex_gland | 0.71524936 |
| 128 | MP0003755_abnormal_palate_morphology | 0.71333548 |
| 129 | MP0003385_abnormal_body_wall | 0.70938905 |
| 130 | MP0005384_cellular_phenotype | 0.70652378 |
| 131 | MP0001346_abnormal_lacrimal_gland | 0.70595437 |
| 132 | MP0001881_abnormal_mammary_gland | 0.70452800 |
| 133 | MP0005075_abnormal_melanosome_morpholog | 0.70075903 |
| 134 | MP0001145_abnormal_male_reproductive | 0.68621859 |
| 135 | MP0003121_genomic_imprinting | 0.67973080 |
| 136 | MP0008438_abnormal_cutaneous_collagen | 0.66531038 |
| 137 | MP0002127_abnormal_cardiovascular_syste | 0.66346936 |
| 138 | MP0010630_abnormal_cardiac_muscle | 0.65570579 |
| 139 | MP0002177_abnormal_outer_ear | 0.65277619 |
| 140 | MP0005391_vision/eye_phenotype | 0.64370257 |
| 141 | MP0000566_synostosis | 0.63856728 |
| 142 | MP0001544_abnormal_cardiovascular_syste | 0.63083702 |
| 143 | MP0005385_cardiovascular_system_phenoty | 0.63083702 |
| 144 | MP0005253_abnormal_eye_physiology | 0.61971484 |
| 145 | MP0003942_abnormal_urinary_system | 0.60742490 |
| 146 | MP0005197_abnormal_uvea_morphology | 0.60016713 |
| 147 | MP0003938_abnormal_ear_development | 0.58357072 |
| 148 | MP0001299_abnormal_eye_distance/ | 0.58049381 |
| 149 | MP0002282_abnormal_trachea_morphology | 0.57634102 |
| 150 | MP0001324_abnormal_eye_pigmentation | 0.57367854 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased hepatocellular lipid droplets (HP:0006565) | 4.41630969 |
| 2 | Abnormality of glycolysis (HP:0004366) | 4.06933139 |
| 3 | Increased serum pyruvate (HP:0003542) | 4.06933139 |
| 4 | Lipid accumulation in hepatocytes (HP:0006561) | 3.96592685 |
| 5 | Cerebral hypomyelination (HP:0006808) | 3.87141134 |
| 6 | Multiple enchondromatosis (HP:0005701) | 3.81925217 |
| 7 | Renal Fanconi syndrome (HP:0001994) | 3.76045907 |
| 8 | Birth length less than 3rd percentile (HP:0003561) | 3.56369457 |
| 9 | Increased intramyocellular lipid droplets (HP:0012240) | 3.47425887 |
| 10 | Hyperglycinemia (HP:0002154) | 3.45260603 |
| 11 | Breast hypoplasia (HP:0003187) | 3.43244735 |
| 12 | Abnormality of the anterior horn cell (HP:0006802) | 3.14970372 |
| 13 | Degeneration of anterior horn cells (HP:0002398) | 3.14970372 |
| 14 | Hypobetalipoproteinemia (HP:0003563) | 3.10780104 |
| 15 | Rhabdomyolysis (HP:0003201) | 3.07393903 |
| 16 | Microvesicular hepatic steatosis (HP:0001414) | 3.03206920 |
| 17 | Carpal bone hypoplasia (HP:0001498) | 3.01866225 |
| 18 | Oral leukoplakia (HP:0002745) | 2.97589367 |
| 19 | 3-Methylglutaconic aciduria (HP:0003535) | 2.93357562 |
| 20 | Hyperglycinuria (HP:0003108) | 2.88396897 |
| 21 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.88337456 |
| 22 | Abnormality of glycine metabolism (HP:0010895) | 2.88337456 |
| 23 | Increased muscle lipid content (HP:0009058) | 2.81827639 |
| 24 | Exercise-induced muscle cramps (HP:0003710) | 2.79983841 |
| 25 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.79690772 |
| 26 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.78809335 |
| 27 | Type I transferrin isoform profile (HP:0003642) | 2.75585854 |
| 28 | Cerebral edema (HP:0002181) | 2.74277795 |
| 29 | Respiratory difficulties (HP:0002880) | 2.72606497 |
| 30 | Trismus (HP:0000211) | 2.71283874 |
| 31 | Aplastic anemia (HP:0001915) | 2.66190957 |
| 32 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.65101952 |
| 33 | Abnormality of serum amino acid levels (HP:0003112) | 2.64420211 |
| 34 | Progressive muscle weakness (HP:0003323) | 2.63777400 |
| 35 | Exertional dyspnea (HP:0002875) | 2.62740815 |
| 36 | Myoglobinuria (HP:0002913) | 2.62078267 |
| 37 | Hyperammonemia (HP:0001987) | 2.61083131 |
| 38 | Acute necrotizing encephalopathy (HP:0006965) | 2.57710429 |
| 39 | Acute encephalopathy (HP:0006846) | 2.54226508 |
| 40 | Hepatic necrosis (HP:0002605) | 2.53598933 |
| 41 | CNS demyelination (HP:0007305) | 2.50934789 |
| 42 | Amniotic constriction ring (HP:0009775) | 2.49252720 |
| 43 | Abnormality of placental membranes (HP:0011409) | 2.49252720 |
| 44 | Optic disc pallor (HP:0000543) | 2.49161289 |
| 45 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.48690925 |
| 46 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.47074865 |
| 47 | Rough bone trabeculation (HP:0100670) | 2.45044233 |
| 48 | Muscle fiber splitting (HP:0003555) | 2.41408713 |
| 49 | Nausea (HP:0002018) | 2.39959337 |
| 50 | Lethargy (HP:0001254) | 2.39439070 |
| 51 | Selective tooth agenesis (HP:0001592) | 2.38288033 |
| 52 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.38269035 |
| 53 | Generalized aminoaciduria (HP:0002909) | 2.37929087 |
| 54 | Increased serum lactate (HP:0002151) | 2.37073292 |
| 55 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.36845345 |
| 56 | Calcaneovalgus deformity (HP:0001848) | 2.36765042 |
| 57 | Increased CSF lactate (HP:0002490) | 2.35772492 |
| 58 | Muscle fiber inclusion bodies (HP:0100299) | 2.35748881 |
| 59 | Megaloblastic anemia (HP:0001889) | 2.35607779 |
| 60 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.34525429 |
| 61 | Nemaline bodies (HP:0003798) | 2.33235862 |
| 62 | Colon cancer (HP:0003003) | 2.33132206 |
| 63 | CNS hypomyelination (HP:0003429) | 2.32846772 |
| 64 | Impulsivity (HP:0100710) | 2.29864136 |
| 65 | Angiofibromas (HP:0010615) | 2.28877531 |
| 66 | Adenoma sebaceum (HP:0009720) | 2.28877531 |
| 67 | Sparse eyelashes (HP:0000653) | 2.28874035 |
| 68 | Hepatocellular necrosis (HP:0001404) | 2.26479615 |
| 69 | Secondary amenorrhea (HP:0000869) | 2.25285073 |
| 70 | Spastic diplegia (HP:0001264) | 2.23795462 |
| 71 | Patellar aplasia (HP:0006443) | 2.21218124 |
| 72 | Pelvic girdle muscle weakness (HP:0003749) | 2.20872889 |
| 73 | Abnormal protein glycosylation (HP:0012346) | 2.20334235 |
| 74 | Abnormal glycosylation (HP:0012345) | 2.20334235 |
| 75 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.20334235 |
| 76 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.20334235 |
| 77 | Premature ovarian failure (HP:0008209) | 2.19970507 |
| 78 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.19740009 |
| 79 | Pallor (HP:0000980) | 2.18929652 |
| 80 | Deformed tarsal bones (HP:0008119) | 2.16940760 |
| 81 | Abnormal cartilage morphology (HP:0002763) | 2.16680105 |
| 82 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.15249692 |
| 83 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.15249692 |
| 84 | Abnormality of the labia minora (HP:0012880) | 2.15214097 |
| 85 | Macrocytic anemia (HP:0001972) | 2.13295823 |
| 86 | Hypolipoproteinemia (HP:0010981) | 2.11286995 |
| 87 | Pancytopenia (HP:0001876) | 2.10976953 |
| 88 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.09009019 |
| 89 | Reduced antithrombin III activity (HP:0001976) | 2.08584502 |
| 90 | Abnormal lung lobation (HP:0002101) | 2.08417148 |
| 91 | Abnormality of the umbilical cord (HP:0010881) | 2.08343229 |
| 92 | Abnormality of renal resorption (HP:0011038) | 2.07358457 |
| 93 | Dicarboxylic aciduria (HP:0003215) | 2.06664523 |
| 94 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.06664523 |
| 95 | Mitochondrial inheritance (HP:0001427) | 2.06513355 |
| 96 | Abnormality of the calcaneus (HP:0008364) | 2.05717092 |
| 97 | Meckel diverticulum (HP:0002245) | 2.05678916 |
| 98 | Shoulder girdle muscle weakness (HP:0003547) | 2.05495669 |
| 99 | X-linked dominant inheritance (HP:0001423) | 2.05316386 |
| 100 | Reticulocytopenia (HP:0001896) | 2.03181385 |
| 101 | Glossoptosis (HP:0000162) | 2.02136589 |
| 102 | Lactic acidosis (HP:0003128) | 2.01956566 |
| 103 | Microretrognathia (HP:0000308) | 2.01541865 |
| 104 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.00814510 |
| 105 | Intrahepatic cholestasis (HP:0001406) | 1.99558337 |
| 106 | Testicular atrophy (HP:0000029) | 1.98817984 |
| 107 | Difficulty climbing stairs (HP:0003551) | 1.96987498 |
| 108 | Respiratory failure (HP:0002878) | 1.96742873 |
| 109 | Postnatal microcephaly (HP:0005484) | 1.96298262 |
| 110 | Ependymoma (HP:0002888) | 1.96049901 |
| 111 | Abnormal number of erythroid precursors (HP:0012131) | 1.94129551 |
| 112 | Abnormality of the ileum (HP:0001549) | 1.93876305 |
| 113 | Abnormality of the preputium (HP:0100587) | 1.93459565 |
| 114 | Hypoglycemic coma (HP:0001325) | 1.93421754 |
| 115 | Abnormality of methionine metabolism (HP:0010901) | 1.93236385 |
| 116 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.92833618 |
| 117 | Abnormality of alanine metabolism (HP:0010916) | 1.92833618 |
| 118 | Emotional lability (HP:0000712) | 1.92811136 |
| 119 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.92661004 |
| 120 | Areflexia of lower limbs (HP:0002522) | 1.91576603 |
| 121 | Distal arthrogryposis (HP:0005684) | 1.90990673 |
| 122 | Palpitations (HP:0001962) | 1.90358171 |
| 123 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.90197075 |
| 124 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.90197075 |
| 125 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.90071871 |
| 126 | Facial cleft (HP:0002006) | 1.89895435 |
| 127 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.87802384 |
| 128 | Progressive macrocephaly (HP:0004481) | 1.86912847 |
| 129 | Leukodystrophy (HP:0002415) | 1.84181372 |
| 130 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.82694939 |
| 131 | Horseshoe kidney (HP:0000085) | 1.82275524 |
| 132 | Cortical dysplasia (HP:0002539) | 1.81170128 |
| 133 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.80866116 |
| 134 | Opisthotonus (HP:0002179) | 1.79886814 |
| 135 | Spastic paraparesis (HP:0002313) | 1.79760055 |
| 136 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.78757413 |
| 137 | Neoplasm of the pancreas (HP:0002894) | 1.77905942 |
| 138 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.76125547 |
| 139 | Gout (HP:0001997) | 1.75964348 |
| 140 | Exercise intolerance (HP:0003546) | 1.75255405 |
| 141 | Methylmalonic aciduria (HP:0012120) | 1.74865406 |
| 142 | Poor suck (HP:0002033) | 1.74820247 |
| 143 | Absent radius (HP:0003974) | 1.74338042 |
| 144 | Hyperalaninemia (HP:0003348) | 1.73349032 |
| 145 | Abnormal trabecular bone morphology (HP:0100671) | 1.73222653 |
| 146 | Abnormal gallbladder physiology (HP:0012438) | 1.68697011 |
| 147 | Cholecystitis (HP:0001082) | 1.68697011 |
| 148 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.68334910 |
| 149 | Hypoplastic pelvis (HP:0008839) | 1.68107003 |
| 150 | Chromsome breakage (HP:0040012) | 1.67157569 |
| 151 | Blindness (HP:0000618) | 1.66928988 |
| 152 | Abnormality of urine glucose concentration (HP:0011016) | 1.66543948 |
| 153 | Glycosuria (HP:0003076) | 1.66543948 |
| 154 | Ragged-red muscle fibers (HP:0003200) | 1.66474919 |
| 155 | Hyperphosphaturia (HP:0003109) | 1.65374379 |
| 156 | Muscle fiber atrophy (HP:0100295) | 1.61809892 |
| 157 | Hypokinesia (HP:0002375) | 1.61605299 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 5.22615192 |
| 2 | VRK2 | 4.50872308 |
| 3 | NEK1 | 3.96836689 |
| 4 | WEE1 | 3.80947493 |
| 5 | EIF2AK1 | 3.03944261 |
| 6 | TESK2 | 2.88401550 |
| 7 | CDC7 | 2.71617807 |
| 8 | NME2 | 2.37949376 |
| 9 | TESK1 | 2.28981281 |
| 10 | LIMK1 | 2.28382829 |
| 11 | TSSK6 | 2.25550736 |
| 12 | BCKDK | 2.18434645 |
| 13 | PLK4 | 2.00699770 |
| 14 | NEK2 | 1.99982464 |
| 15 | EPHA2 | 1.89607840 |
| 16 | MAP3K12 | 1.86477194 |
| 17 | SRPK1 | 1.81411092 |
| 18 | MST4 | 1.80301514 |
| 19 | TTK | 1.77090075 |
| 20 | PDK3 | 1.68760945 |
| 21 | PDK4 | 1.68760945 |
| 22 | ACVR1B | 1.62200416 |
| 23 | PLK1 | 1.61941379 |
| 24 | BRSK2 | 1.60801162 |
| 25 | PLK3 | 1.58535879 |
| 26 | SCYL2 | 1.57091842 |
| 27 | TRIM28 | 1.42307088 |
| 28 | LATS2 | 1.40209602 |
| 29 | MAP3K8 | 1.39224404 |
| 30 | AURKB | 1.36259192 |
| 31 | AURKA | 1.36076161 |
| 32 | EIF2AK3 | 1.34700775 |
| 33 | PKN2 | 1.33774054 |
| 34 | RPS6KB2 | 1.33098264 |
| 35 | TTN | 1.27666745 |
| 36 | STK16 | 1.21951426 |
| 37 | TRIB3 | 1.21817071 |
| 38 | BRSK1 | 1.20111525 |
| 39 | CSNK1G3 | 1.16731047 |
| 40 | OBSCN | 1.14587544 |
| 41 | PBK | 1.13895934 |
| 42 | NME1 | 1.11938415 |
| 43 | DYRK3 | 1.08592604 |
| 44 | PAK4 | 1.07777818 |
| 45 | BRAF | 1.05817642 |
| 46 | PASK | 1.03462629 |
| 47 | LRRK2 | 1.01169917 |
| 48 | PDK2 | 1.00705837 |
| 49 | VRK1 | 1.00051573 |
| 50 | RPS6KA4 | 0.99983300 |
| 51 | MAP3K11 | 0.99065006 |
| 52 | TAF1 | 0.98043577 |
| 53 | ARAF | 0.97115921 |
| 54 | CDK8 | 0.96211307 |
| 55 | STK38L | 0.95615554 |
| 56 | TLK1 | 0.95473959 |
| 57 | CDK7 | 0.94643223 |
| 58 | ZAK | 0.92062149 |
| 59 | CSNK1G1 | 0.91107179 |
| 60 | ILK | 0.89319929 |
| 61 | KDR | 0.88380029 |
| 62 | ATR | 0.88279888 |
| 63 | CSNK1A1L | 0.87719318 |
| 64 | DAPK1 | 0.87629154 |
| 65 | TGFBR1 | 0.86879553 |
| 66 | CSNK1G2 | 0.85626364 |
| 67 | MAPKAPK3 | 0.84585344 |
| 68 | PNCK | 0.83904528 |
| 69 | CHEK1 | 0.83315264 |
| 70 | PAK1 | 0.82375624 |
| 71 | CHEK2 | 0.81515781 |
| 72 | CDK4 | 0.79175473 |
| 73 | PIM2 | 0.78493863 |
| 74 | NUAK1 | 0.76852147 |
| 75 | MAP2K7 | 0.76261452 |
| 76 | MKNK1 | 0.73935349 |
| 77 | MST1R | 0.73030538 |
| 78 | ALK | 0.71830605 |
| 79 | ABL2 | 0.67928096 |
| 80 | CSNK2A2 | 0.65206346 |
| 81 | PLK2 | 0.64655322 |
| 82 | MINK1 | 0.63005249 |
| 83 | MAP4K2 | 0.62122307 |
| 84 | CLK1 | 0.62078928 |
| 85 | MYLK | 0.62006058 |
| 86 | MAP3K3 | 0.61853310 |
| 87 | MET | 0.61367627 |
| 88 | CSNK2A1 | 0.60660452 |
| 89 | MAP2K3 | 0.58347158 |
| 90 | KSR2 | 0.58021390 |
| 91 | DYRK2 | 0.56852497 |
| 92 | CDK2 | 0.56655835 |
| 93 | ERBB4 | 0.55544534 |
| 94 | CDK19 | 0.54771280 |
| 95 | PRKCI | 0.53488872 |
| 96 | WNK3 | 0.52770242 |
| 97 | DAPK3 | 0.52722207 |
| 98 | CCNB1 | 0.52715055 |
| 99 | EIF2AK2 | 0.52714791 |
| 100 | STK4 | 0.51896471 |
| 101 | MUSK | 0.50685047 |
| 102 | FGFR1 | 0.49972260 |
| 103 | EPHB2 | 0.49092595 |
| 104 | CSNK1E | 0.48803949 |
| 105 | STK10 | 0.48210058 |
| 106 | PHKG1 | 0.48023403 |
| 107 | PHKG2 | 0.48023403 |
| 108 | CDK18 | 0.45804798 |
| 109 | MKNK2 | 0.44281127 |
| 110 | CDK11A | 0.44275822 |
| 111 | ERBB3 | 0.44062980 |
| 112 | IRAK3 | 0.42960586 |
| 113 | NEK9 | 0.42754549 |
| 114 | CDK15 | 0.42556096 |
| 115 | MTOR | 0.41078986 |
| 116 | MELK | 0.39097843 |
| 117 | FLT3 | 0.38754721 |
| 118 | CDK1 | 0.38608015 |
| 119 | MAP2K2 | 0.38464681 |
| 120 | EEF2K | 0.36898641 |
| 121 | BMPR1B | 0.36823363 |
| 122 | AKT2 | 0.36413610 |
| 123 | MAP2K1 | 0.36202787 |
| 124 | CDK14 | 0.35994321 |
| 125 | ATM | 0.35982705 |
| 126 | CDK6 | 0.34882243 |
| 127 | RPS6KA5 | 0.33610847 |
| 128 | TAOK2 | 0.33231519 |
| 129 | MAP3K5 | 0.32668345 |
| 130 | MAP3K10 | 0.32582629 |
| 131 | MAPKAPK5 | 0.31991186 |
| 132 | BCR | 0.26320794 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Proteasome_Homo sapiens_hsa03050 | 4.23482763 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 3.05565890 |
| 3 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.86653679 |
| 4 | RNA polymerase_Homo sapiens_hsa03020 | 2.81565365 |
| 5 | Ribosome_Homo sapiens_hsa03010 | 2.63328973 |
| 6 | RNA transport_Homo sapiens_hsa03013 | 2.52900184 |
| 7 | Mismatch repair_Homo sapiens_hsa03430 | 2.48206892 |
| 8 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.47928458 |
| 9 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.43516708 |
| 10 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.36257445 |
| 11 | Spliceosome_Homo sapiens_hsa03040 | 2.33079359 |
| 12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.29615609 |
| 13 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.24906913 |
| 14 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.01428273 |
| 15 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.00254799 |
| 16 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.97730726 |
| 17 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.94645433 |
| 18 | Carbon metabolism_Homo sapiens_hsa01200 | 1.93002778 |
| 19 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.87552021 |
| 20 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.81173552 |
| 21 | Cell cycle_Homo sapiens_hsa04110 | 1.70372327 |
| 22 | Base excision repair_Homo sapiens_hsa03410 | 1.65279659 |
| 23 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.53774160 |
| 24 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.52155320 |
| 25 | Parkinsons disease_Homo sapiens_hsa05012 | 1.51430185 |
| 26 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.45695778 |
| 27 | Homologous recombination_Homo sapiens_hsa03440 | 1.40516742 |
| 28 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.40462230 |
| 29 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.38717386 |
| 30 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.38093843 |
| 31 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.37177194 |
| 32 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.34044436 |
| 33 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.28384858 |
| 34 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.25882000 |
| 35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.20681375 |
| 36 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.19039285 |
| 37 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.16407025 |
| 38 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.16278646 |
| 39 | Huntingtons disease_Homo sapiens_hsa05016 | 1.15173889 |
| 40 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.12442688 |
| 41 | Sulfur relay system_Homo sapiens_hsa04122 | 1.09326530 |
| 42 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.08156763 |
| 43 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.08064990 |
| 44 | Basal transcription factors_Homo sapiens_hsa03022 | 1.06771328 |
| 45 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.06299689 |
| 46 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.05966508 |
| 47 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.04467293 |
| 48 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.02673593 |
| 49 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.00269775 |
| 50 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.96118849 |
| 51 | Purine metabolism_Homo sapiens_hsa00230 | 0.95187678 |
| 52 | RNA degradation_Homo sapiens_hsa03018 | 0.94455712 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.92128136 |
| 54 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.90701793 |
| 55 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.85417001 |
| 56 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.82541028 |
| 57 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.82443231 |
| 58 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.82075095 |
| 59 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.81980847 |
| 60 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.81548636 |
| 61 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.81014405 |
| 62 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.81003668 |
| 63 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.80154547 |
| 64 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.77808455 |
| 65 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.77068815 |
| 66 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.74717943 |
| 67 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.72254957 |
| 68 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.70606640 |
| 69 | Peroxisome_Homo sapiens_hsa04146 | 0.69825810 |
| 70 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.68290705 |
| 71 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.68283874 |
| 72 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.66933929 |
| 73 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.64054218 |
| 74 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.64029514 |
| 75 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.63884145 |
| 76 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.60310303 |
| 77 | Alzheimers disease_Homo sapiens_hsa05010 | 0.60285166 |
| 78 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.58878099 |
| 79 | Metabolic pathways_Homo sapiens_hsa01100 | 0.58295498 |
| 80 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.54055243 |
| 81 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.53873533 |
| 82 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.51693331 |
| 83 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.48551958 |
| 84 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.48327074 |
| 85 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.48171235 |
| 86 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.47114573 |
| 87 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.47049727 |
| 88 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.46715088 |
| 89 | Histidine metabolism_Homo sapiens_hsa00340 | 0.43031356 |
| 90 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.42448407 |
| 91 | Legionellosis_Homo sapiens_hsa05134 | 0.40059444 |
| 92 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.38633907 |
| 93 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.37851434 |
| 94 | Thyroid cancer_Homo sapiens_hsa05216 | 0.37623117 |
| 95 | Galactose metabolism_Homo sapiens_hsa00052 | 0.37333509 |
| 96 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.36187812 |
| 97 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.35546679 |
| 98 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.34298604 |
| 99 | Protein export_Homo sapiens_hsa03060 | 0.32669610 |
| 100 | Retinol metabolism_Homo sapiens_hsa00830 | 0.27971273 |
| 101 | Bladder cancer_Homo sapiens_hsa05219 | 0.26960433 |
| 102 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.26278888 |
| 103 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.25320084 |
| 104 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.24963510 |
| 105 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.24709432 |
| 106 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.23664116 |
| 107 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.20967812 |
| 108 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.19214104 |
| 109 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.12905304 |
| 110 | Phototransduction_Homo sapiens_hsa04744 | 0.07011075 |
| 111 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.06644695 |
| 112 | Shigellosis_Homo sapiens_hsa05131 | 0.04280753 |
| 113 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.03723384 |

